Concepedia

Lyn Ley Lam

LL

Statistics

Publications

1

Citations

28

H-Index

1

Active since

2023

Affiliations

Monash University(Current)

Lyn Ley Lam is an author at Monash University specializing in oncology pharmacotherapy, therapeutic tyrosine kinase inhibitors, and combination cancer therapy.

Publications per year

2023–2023

1

Publications

1

INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG)

Lyn Ley Lam, Nick Pavlakis, Kohei Shitara et al. · BMC Cancer · 2023 · 28 citations · Full text

Medicine, Oncology, Pharmacotherapy +10

1–1 of 1